These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of IL-12 treatment on vaccine-enhanced illness during infection with respiratory syncytial virus. Openshaw PJ; Hussell T Dev Biol Stand; 1998; 92():179-85. PubMed ID: 9554273 [TBL] [Abstract][Full Text] [Related]
24. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes. Whitehead SS; Firestone CY; Collins PL; Murphy BR Virology; 1998 Aug; 247(2):232-9. PubMed ID: 9705916 [TBL] [Abstract][Full Text] [Related]
25. [Respiratory syncytial virus and immune response: from the diagnosis of infection to prospects of vaccination]. Pothier P Pediatrie; 1991; 46(8-9 Suppl):1-4. PubMed ID: 1665219 [No Abstract] [Full Text] [Related]
33. A puzzling respiratory virus. Br Med J; 1970 Feb; 1(5692):317. PubMed ID: 5416807 [No Abstract] [Full Text] [Related]
34. Immunopathology of RSV infection: prospects for developing vaccines without this complication. van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology of severe respiratory syncytial virus infections in Huntington, West Virginia. Belshe RB; Van Voris LP; Mufson MA; Hyler L W V Med J; 1981 Mar; 77(3):49-52. PubMed ID: 6958122 [No Abstract] [Full Text] [Related]